Latest:

Fat Pitch Financials

Special situation stocks and value investing

Stock Quote

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Olink Holding Ab [Publ] ADR (NQ: OLK )

21.09 +0.89 (+4.41%)
Streaming Delayed Price Updated: 12:29 PM EDT, Jun 6, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 32,068
Open 20.25
Bid (Size) 20.84 (4)
Ask (Size) 21.17 (4)
Prev. Close 20.20
Today's Range 19.84 - 21.19
52wk Range 8.390 - 26.47
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Olink to participate in June investor events
From Olink Proteomics AB
Via GlobeNewswire
Olink Holding: Q1 Earnings Insights
 
Via Benzinga

Performance

YTD
-6.22%
-6.22%
1 Month
-4.35%
-4.35%
3 Month
-12.53%
-12.53%
6 Month
-4.14%
-4.14%
1 Year
+74.30%
+74.30%

More News

Read More
Olink reports first quarter 2023 financial results
From Olink Proteomics AB
Via GlobeNewswire
Report from the Annual General Meeting of Olink Holding AB (publ) on 17 April 2023
From Olink Proteomics AB
Via GlobeNewswire
Analyst Ratings for Olink Holding
Via Benzinga
Olink Holding's Earnings Outlook
Via Benzinga
Why Olink Shares Are Trading Lower Today?
Via Benzinga
Olink to report first quarter 2023 financial results on May 11, 2023
From Olink Proteomics AB
Via GlobeNewswire
Swedish Olink technology enables further development of South African research and innovation
From Olink Proteomics AB
Via GlobeNewswire
Olink publishes 2022 annual report
From Olink Proteomics AB
Via GlobeNewswire
Bruno Rossi joins Olink as Chief Commercial Officer
From Olink Proteomics AB
Via GlobeNewswire
Notice to attend the Annual General Meeting of Olink Holding AB (publ)
From Olink Proteomics AB
Via GlobeNewswire
NUS Medicine implements Olink technology to accelerate precision medicine through next-generation proteomics
From Olink Proteomics AB
Via GlobeNewswire
Olink establishes agreement with Regeneron Genetics Center to scale their proteomics efforts, potentially enabling a new era of drug discovery
From Olink Proteomics AB
Via GlobeNewswire
Olink reports fourth quarter and full year 2022 financial results
From Olink Proteomics AB
Via GlobeNewswire
The 7 Best Manufacturing Stocks to Buy for 2023
Via InvestorPlace
Why Jupiter Wellness Shares Are Trading Lower By Around 40%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
Dow Falls 200 Points; Jobless Claims Drop To 4-Month Low
Via Benzinga
Why Is NuZee (NUZE) Stock On The Move Today?
Via InvestorPlace
Why Is Olink (OLK) Stock Down 17% Today?
Via InvestorPlace
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Why Starbox Group Shares Are Trading Higher By 22%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
Via InvestorPlace
Alcoa, H.B. Fuller And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
Via Benzinga
Olink Holding AB (publ) announces pricing of public offering of American Depositary Shares
From Olink Proteomics AB
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.